Article
The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes.
Drug metabolism and pharmacokinetics - 1 Apr 2021
Kimura Yuki, Higuchi Issei, Kobayashi Masaki, Furugen Ayako, Narumi Katsuya, Suzuki Yuya, Miyoshi Hideaki, Nakamura Akinobu, Atsumi Tatsuya, Iseki Ken
Abstract excerpt
Solute carrier (SLC) 16A11 has been reported as a risk gene for type 2 diabetes (T2D). However, the physiological function of SLC16A11 has not yet been clarified, and the relationship between SLC16A11 and T2D condition remains unclear. Therefore, we performed an association analysis between the SLC16A11 genotype and T2D pathology. The SLC16A11 genotype was determined by direct sequencing in 85 Japanese patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
